Status:
UNKNOWN
Chicago Classification Normative Metrics in a Healthy Russian Cohort According to High-resolution Esophageal Manometry
Lead Sponsor:
Russian Academy of Medical Sciences
Conditions:
Healthy
Eligibility:
All Genders
18-65 years
Brief Summary
High resolution esophageal manometry normative values are still need to be studied in different populations and with the use of solid-state and water-perfused systems. There has been no study on the s...
Detailed Description
High-resolution esophageal manometry (HREM) is the current modality used to evaluate esophageal motility. There are 2 types of system: water-perfused system that is cheaper to maintain and a solid-sta...
Eligibility Criteria
Inclusion
- Inclusion Criteria (all points are necessary for inclusion):
- Willingness to participate on the basis of signed informed consent form;
- Patients of both sexes, aged 18 to 65 years inclusive;
- Permanent residence in the Russian Federation;
- Absence of esophageal diseases, confirmed by the results of clinical and instrumental examination
- Ability to follow instructions during high-resolution esophageal manometry procedure
- Exclusion Criteria (patient is not eligible when at least one exclusion criterion is met):
- diseases of the esophagus (any condition on the basis of clinical and / or instrumental examination, including: complaints of heartburn, belching, difficulty to swallow solid and/or liquid food;
- any surgical intervention on the gastrointestinal tract and / or chest organs in medical history;
- solid organ transplantation in medical history with the exception of a corneal transplant and surgery to replace the lens of the eye;
- any oncology of any localization except for skin cancer in situ in the medical history;
- any decompensated diseases of any organs and systems, which, in the opinion of the researcher, makes it impossible to carry out the procedure of esophageal manometry of high resolution or if the procedure may cause the risk of deterioration of the patient's condition;
- any condition, clinical and laboratory signs of alcohol abuse (abuse will be assessed in the case of male subjects consuming more than 30 g of pure alcohol per day and using more than 20 g of pure alcohol per day by female subjects;
- any illegal drug use, current or past;
- use of concomitant medications that can affect esophageal motility including, but not limited to: calcium channel blockers, metoclopramide, m-cholinolytics, domperidone, erythromycin, nitrates, tricyclic antidepressants, opiates, beta-blockers, beta-adrenomimetics, alcohol. The duration of the period of non-use of these drugs should provide sufficient time for the complete cessation of their pharmacological action, but not less than two half-life.
- pregnant or breastfeeding women
- any condition making impossible to perform high resolution esophageal manometry (previously known poor tolerability of the procedure; narrow nasal passages; significant curvature of the nasal septum etc).
Exclusion
Key Trial Info
Start Date :
February 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03829865
Start Date
February 4 2019
End Date
December 31 2023
Last Update
April 26 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Gastroenterology and Hepatology, FRC Nutrition and Biotechnology
Moscow, Russia, 115446
2
Moscow clinical hospital #31
Moscow, Russia, 119415
3
Pavlov First Saint Petersburg State Medical University. Endoscopy Department
Saint Petersburg, Russia, 197022